JACC: Cardiovascular Interventions ( IF 11.7 ) Pub Date : 2020-12-21 , DOI: 10.1016/j.jcin.2020.08.038
Abdul Hussain Azizi 1 , Irfan Shafi 2 , Neal Shah 1 , Kenneth Rosenfield 3 , Robert Schainfeld 3 , Akhilesh Sista 4 , Riyaz Bashir 5
![]() |
Superior vena cava (SVC) syndrome comprises a constellation of clinical signs and symptoms caused by obstruction of blood flow through the SVC. The management of patients with life-threatening SVC syndrome is evolving from radiation therapy to endovascular therapy as the first-line treatment. There is a paucity of data and societal guidelines with regard to the management of SVC syndrome. This paper aims to update the practicing interventionalists with the contemporary and the evolving therapeutic approach to SVC syndrome. In addition, the review will focus on endovascular techniques, including catheter-directed thrombolysis, angioplasty, and stenting, and their associated complications.
中文翻译:
![](https://scdn.x-mol.com/jcss/images/paperTranslation.png)
上腔静脉综合征
上腔静脉 (SVC) 综合征包括由通过 SVC 的血流受阻引起的一系列临床体征和症状。危及生命的 SVC 综合征患者的治疗正在从放射治疗发展为作为一线治疗的血管内治疗。关于 SVC 综合征管理的数据和社会指南很少。本文旨在通过当代和不断发展的 SVC 综合征治疗方法更新执业介入医师。此外,审查将集中于血管内技术,包括导管定向溶栓、血管成形术和支架置入术,以及它们的相关并发症。